Clinical Trial Update: Neoadjuvant Prolgolimab Monotherapy in Locally Advanced MMR-deficient Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant monotherapy trial of prolgolimab for locally advanced mismatch repair-deficient colorectal cancer is currently recruiting. Sponsor: Blokhin'…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Prolgolimab (prolgolimab)

Snippet

Sponsor: Blokhin's Russian Cancer Research Center | Conditions: Colorectal Cancer | Phase 2 | Status: RECRUITING